HCPCS Level IIdrugActive
J3389
Topi adm prad zami per treat
BETOS: O1E
Effective: 2026-01-01
Description
Topical administration, prademagene zamikeracel, per treatment
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Zevaskyn
Manufacturer
Abeona Therapeutics Inc.
HCPCS Dosage
Per Therapeutic Dose
Billing Units
1.0000
1
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.